{"abstract": "Victrelis, from Merck, is the first of a new generation of drugs that promise to increase the cure rate while shortening the treatment time.", "web_url": "https://www.nytimes.com/2011/05/14/business/14drug.html", "snippet": "Victrelis, from Merck, is the first of a new generation of drugs that promise to increase the cure rate while shortening the treatment time.", "lead_paragraph": "The Food and Drug Administration approved on Friday the first of a new generation of hepatitis C drugs that promises to increase the cure rate while shortening the time required for treatment.", "print_section": "B", "print_page": "6", "source": "The New York Times", "multimedia": [], "headline": {"main": "Merck\u2019s Hepatitis C Drug Wins F.D.A. Approval", "kicker": null, "content_kicker": null, "print_headline": "Merck\u2019s Hepatitis C Drug Wins F.D.A. Approval", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "organizations", "value": "Merck & Company Inc", "rank": 1, "major": "N"}, {"name": "subject", "value": "Medicine and Health", "rank": 2, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 3, "major": "N"}, {"name": "organizations", "value": "Food and Drug Administration", "rank": 4, "major": "N"}, {"name": "subject", "value": "Hepatitis", "rank": 5, "major": "N"}], "pub_date": "2011-05-13T23:17:20+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Andrew Pollack", "person": [{"firstname": "Andrew", "middlename": null, "lastname": "Pollack", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/12afdde7-d2c8-5224-8ed5-d7318e192a1f", "word_count": 741, "uri": "nyt://article/12afdde7-d2c8-5224-8ed5-d7318e192a1f"}